FTLF
FITLIFE BRANDS, INC.
Next earnings Aug 12, 2026 · consensus $0.20 EPS, $26.5M rev
Last earnings +7.5% on 2026-05-14
$11.50
▲ +3.98%$11.50▼ -10.23%
over 1Y
L $8.88H $20.76
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+4.0%
1W-3.6%
1M+18.3%
3M+8.4%
YTD-27.0%
1Y-10.2%
Hold
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••
Street · 8 analysts
Buy
Revenue compounding via the Irwin deal, but FY25 earnings fell 31% and Amazon/GNC concentration caps the multiple — own, don't chase.
Revenue $81.5M · FY2025
The read
Middling fundamentals and a rich price (~53% above fair value) leave little margin of safety — a wait-and-see.
FitLife is a real, profitable supplements operator that has tripled revenue in four years ($27.9M FY21 → $81.5M FY25, +26.4% in FY25 alone) while staying solidly cash-generative ($7.44M operating cash flow) and posting a healthy 14.5% ROE. At $11.06 it trades on 17.6x trailing EPS and just 1.3x sales — neither cheap nor demanding for a business growing the top line at this clip. On the surface that combination looks like a buy.
The problem is earnings quality has gone the wrong way. Despite revenue rising 26%, net income fell 29.6% to $6.33M, diluted EPS dropped 30.8% to $0.63, operating income fell 23.3% and operating cash flow fell 22.6%. Net margin is down to 7.8% and gross margin (38.6%) only grew 12% versus 26% revenue. The tell is on the balance sheet: total assets jumped 81.6% and total liabilities surged 179.8% — consistent with the debt-funded Irwin Naturals acquisition the MD&A references. So the headline growth is bought, not organic-margin-accretive, and the integration is currently diluting profitability and adding leverage (liabilities/equity now 1.44x). The P/E is being paid on a depressed, transitional earnings base.
Is FTLF a buy? The one-page verdict, explained →
The options angle
model · matches our verdictCovered call~60d expiry
- Long 100 shares @ ~11.50
- Short call 12 @ ~1.17 est
debit $1,033max +$167max −$1,032BE 10.33
HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $27.9M | $28.8M | $52.7M | $64.5M | $81.5M |
| Gross profit | $12.5M | $12.0M | $21.4M | $28.1M | $31.5M |
| Operating income | $6.23M | $5.70M | $7.55M | $13.1M | $10.1M |
| Net income | $5.41M | $4.43M | $5.30M | $8.98M | $6.33M |
| Diluted EPS | $1.13 | $0.89 | $0.54 | $0.91 | $0.63 |
| Net margin | 19.4% | 15.4% | 10.0% | 13.9% | 7.8% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$110M
EV / EBITDA10.5
EV / Sales1.4
EV / FCF14.9
P / FCF14.6
PEG (trailing)—
Earnings yield5.9%
FCF yield6.8%
Quality & risk
ROIC (est.)15.2%
Free cash flow$7.40M
Total debt$8.55M
Net cash-$2.21M
Altman Z-Score2.40 grey
Piotroski F-Score4/9
Capital returns
Buyback yield0.0%
Dividend yield (est.)0.0%
Shareholder yield0.0%
Shares Δ YoY+1.9%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRecent disclosure tone has skewed negative — read the flagged items.
- DEF 14A Proxy statement2026-06-26
2026 proxy: annual meeting, director slate and exec comp up for vote
- 8-K Officer / director change2026-05-22
Board/officer change disclosed (Item 5.02); leadership or comp update
- 8-K Earnings results2026-05-14
Q1 2026 (per 3/31): first full post-Irwin quarter; latest results filed
- 10-Q Quarterly report2026-05-14
Q1 2026 (per 3/31): first full post-Irwin quarter; latest results filed
- 10-K/A Restated periodic report2026-04-21
Amended FY2025 10-K (Part III/proxy info); no restatement
- 8-K Reg FD disclosure2026-04-07
Reg FD investor update/exhibit furnished (Item 7.01); no new financials
- 8-K Earnings results2026-04-01
Furnished FY2025 results: revenue +26% to $81.5M but net income -30%
- 10-K Annual report2026-03-31
FY2025: revenue +26% to $81.5M; EPS -31%, leverage up post-Irwin deal
- 8-K Reg FD disclosure2025-12-10
Reg FD disclosure furnished (Item 7.01); no new financial data
Recent filings
all on EDGAR ↗DEFA14AFiling2026-06-26open ↗DEFA14AFiling2026-06-26open ↗DEF 14APeriod ending 2026-08-112026-06-26open ↗8-KPeriod ending 2026-05-182026-05-22open ↗4Period ending 2026-05-152026-05-19open ↗8-KPeriod ending 2026-05-142026-05-14open ↗10-QPeriod ending 2026-03-312026-05-14open ↗10-K/APeriod ending 2025-12-312026-04-21open ↗4Period ending 2026-01-152026-04-20open ↗5Period ending 2025-12-312026-04-20open ↗4Period ending 2026-04-102026-04-14open ↗4Period ending 2026-04-102026-04-14open ↗
Frequently asked
- Is FITLIFE BRANDS, INC. (FTLF) a buy?
- FTLF currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Revenue compounding via the Irwin deal, but FY25 earnings fell 31% and Amazon/GNC concentration caps the multiple — own, don't chase.
- What is FTLF's fair value?
- A Modified-Graham model based on FTLF's SEC fundamentals estimates a fair value of about $5.36. It is an estimate from reported earnings, not a price target.
- Is FTLF overvalued or undervalued?
- Against a Modified-Graham fair-value estimate, FTLF currently appears overvalued relative to its SEC-grounded earnings power.
- What is FITLIFE BRANDS, INC.'s quality score?
- FTLF scores 65.51240159278134/100 (grade B-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001374328, latest 10-Q filed 2026-05-14) · EODHD · Proprietary analysis · as of 6/30/2026, 11:53:25 AM.
About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 30, 2026, 7:53 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.